FDA confirms news on Medtronic Sprint Fidelis Leads | Searcy Law Skip to Content
Contact Form Live Chat Review Us Map & Directions Videos

News from the FDA Concerning Medtronic Sprint Fidelis Leads


On August 28, 2008, I posted a story about Medtronic’s defective Sprint Fidelis defibrillator leads on InjuryBoard.com.

The story mentioned the difficulty surgeons would encounter in removing the defective Medtronic leads. In the meanwhile, the FDA and Medtronic have been cooperating to arrive at a workable interim solution to enable doctors to track down potential lead fracture. Today, the FDA approved Medtronic software update that gives doctors the capability of monitoring and identifying potential defibrillator lead fractures on a 24 hour basis. The ability to determine when and where lead fractures are occurring will benefit patients who may require crucial medical intervention.

Share This

What Our Clients Have To Say

" The attorneys and staff at Searcy Denney are some of the most compassionate and caring individuals I have met in the legal field. They work tirelessly on behalf of their clients to ensure the best possible outcome. I would highly recommend them for anyone who is seeking excellent legal representation. "